News Conference News AHA 2021 Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF Michael O'Riordan November 19, 2021
News Daily News New Chest Pain Guidelines Out at Last: Most Tests Have a Role Michael O'Riordan October 28, 2021
News Daily News High Burden of CAD in Chest Pain Patients With ‘Normal’ Troponin Michael O'Riordan September 27, 2021
News Daily News Biomarker Levels ID Patients With Most to Gain From Intensive BP Lowering Todd Neale September 08, 2021
News Features Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI? Michael O'Riordan December 02, 2020
News Daily News CMR Picks Up Pericardial Inflammation in Student Athletes With COVID-19 Michael O'Riordan November 06, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2020 Shelley Wood October 01, 2020
News Daily News ABC-Bleeding Score Stratifies Risk in A-fib Patients on OAC and Aspirin Todd Neale September 21, 2020
News Daily News High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention Michael O'Riordan August 11, 2020
News Features COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions Shelley Wood July 20, 2020
News Daily News Thrombus Burden Greater in STEMI Patients With COVID-19 Michael O'Riordan July 20, 2020
News Daily News How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions Michael O'Riordan April 22, 2020
News Daily News Cardiac Considerations Amid COVID-19: Shared Stories May Save Lives L.A. McKeown March 25, 2020
News Daily News Type 2 MI Linked to More CV Deaths, Even in Younger Patients Shelley Wood March 04, 2020
News Daily News Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients Michael O'Riordan August 22, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Daily News CEC Identifies ‘Prognostically Important’ MIs: CHAMPION PHOENIX Michael O'Riordan July 30, 2019
News Daily News Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure Michael O'Riordan May 06, 2019
News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018